Stay updated on Cabozantinib in Advanced Solid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Solid Malignancies Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedLocations section added with Massachusetts as a location, replacing the old Massachusetts Locations entry. HHS Vulnerability Disclosure removed and page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page now shows revision tag v3.3.1 replacing the previous v3.2.0 tag, indicating a metadata update. This change does not affect the study details or content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedRemoved the funding-status alert banner that informed users about potential data staleness and NIH operating status; the page no longer displays that disclaimer.SummaryDifference0.4%

- Check59 days agoChange DetectedThe changes are limited to minor UI adjustments and wording updates that do not alter the study's inclusion criteria, endpoints, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check87 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference4%

Stay in the know with updates to Cabozantinib in Advanced Solid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.